nature neurOSCIenCe a r t I C l e S Dopaminergic neurotransmission is important for habit formation, motor learning and reward-seeking behaviors, and abnormalities in dopamine transmission underlie important features of psychiatric and neurological disorders. Elucidating mechanisms that regulate dopamine release is essential for understanding normal and diseased brain function. Striatal dopamine exocytosis has been characterized with high chemical specificity by microdialysis 1 and high temporal resolution with carbon fiber cyclic voltammetry (CV) and amperometry 2, 3 . Although these methods have greatly advanced our knowledge of dopaminergic neurotransmission, they integrate release and reuptake from hundreds of boutons and lack the ability to monitor the range of responses and spatial dynamics of transmitter release from individual synapses.
a r t I C l e S Dopaminergic neurotransmission is important for habit formation, motor learning and reward-seeking behaviors, and abnormalities in dopamine transmission underlie important features of psychiatric and neurological disorders. Elucidating mechanisms that regulate dopamine release is essential for understanding normal and diseased brain function. Striatal dopamine exocytosis has been characterized with high chemical specificity by microdialysis 1 and high temporal resolution with carbon fiber cyclic voltammetry (CV) and amperometry 2, 3 . Although these methods have greatly advanced our knowledge of dopaminergic neurotransmission, they integrate release and reuptake from hundreds of boutons and lack the ability to monitor the range of responses and spatial dynamics of transmitter release from individual synapses.
Electron microscopy studies have suggested morphological heterogeneity of striatal dopaminergic synapses, with a fraction of synaptic vesicle-containing axonal sites lacking synaptic membrane densities 4, 5 . Little is known, however, about the functional range of dopaminergic 'presynaptic sites' in the striatum. Optical techniques provide the spatial resolution required to address these issues. Endocytic FM dyes 6 and the genetically encoded synaptopHluorins 7 have been used to study dopaminergic exocytosis in cultured neurons [8] [9] [10] [11] . These probes, however, are not specific for dopamine boutons, and post hoc immunostaining is required to confirm dopaminergic identity, which is impractical when studying brain tissue. We recently introduced the fluorescent false neurotransmitters (FFNs) FFN511 and FFN102, fluorescent dopamine analogs that let us detect transmitter release from dopamine boutons in brain tissue 12, 13 . These FFNs, however, possess intrinsic characteristics that complicate the accurate monitoring of destaining kinetics and do not successfully label dopaminergic synapses in cultured neurons.
We developed FFN200 as the first FFN to label dopaminergic neurons in both culture and the acute brain slice. We found that the majority of striatal FFN200-labeled axonal sites loaded the probe into VMAT2-containing vesicles and exhibited electrically evoked GCaMP3-monitored Ca 2+ transients. Only a small fraction of these vesicle clusters, however, exhibited exocytosis in response to local electrical stimulation, which was independently confirmed by the well-characterized endocytic tracer FM1-43. Our results suggest that, in dopaminergic axons, the majority of vesicle clusters capable of accumulating neurotransmitter are functionally silent, as a result of a blockade of exocytosis at a step downstream from Ca 2+ influx.
RESULTS

FFN200 selectively labels striatal dopamine axons
With the aim of developing optical probes to study monoamine exocytosis from individual boutons, we designed FFN200 as a fluorescent substrate of VMAT2 (Fig. 1a) , the predominant isoform of the synaptic vesicle monoamine transporter in the CNS 14 . FFN200 was confirmed a r t I C l e S as a VMAT2 substrate, as its accumulation in VMAT2-transfected HEK cells was inhibited by tetrabenazine (TBZ) and exhibited a K m of 13.7 ± 2.7 µM (n = 3, Online Methods). The fluorescence excitation and emission maxima of FFN200 were determined to be 352 and 451 nm (Fig. 1b) , respectively, allowing good spectral separation from most green and red fluorophores. The logD of FFN200, which indicates the probe's partition between octanol and pH 7.4 potassium phosphate buffer, was −1.29, indicating that FFN200 is a highly polar compound unlikely to diffuse across membranes. Striatal brain slices incubated with FFN200 exhibited a punctate pattern of fluorescent labeling that was suggestive of synaptic bouton staining (Fig. 1c) . To investigate the selectivity of FFN200 toward dopaminergic structures, we used striatal slices from mice expressing GFP under the tyrosine hydroxylase promoter (TH-GFP mice) 15 . In the striatum, GFP was expressed mostly in dopaminergic axons, the predominant monoaminergic input to this brain region 16, 17 . The majority of FFN200 puncta colocalized with GFP (84.6 ± 2.6%, n = 5 slices from 5 mice; Fig. 1c) , indicating that the probe is selective for striatal dopaminergic axonal profiles and ruling out a substantial fraction of serotonergic boutons.
Given that no monoamine-specific optical tracers have been identified that monitor exocytosis in cultured dopaminergic neurons, we analyzed FFN200 staining of TH-GFP ventral midbrain neuronal cultures. Approximately 70% of cultured dopamine neurons, identified by the presence of GFP, were found to accumulate FFN200 (Supplementary Fig. 1 ). Conversely, 100% of FFN200-positive cells were immunolabeled for TH after FFN200 imaging (immunolabeling for TH was performed, as not all cultured TH-positive neurons from TH-GFP mouse expressed GFP; Fig. 1d ). These results indicate that FFN200 selectively labels ventral midbrain dopaminergic cell bodies in culture.
To determine whether there is differential accumulation of FFN200 between substantia nigra (SN) and ventral tegmental area (VTA) dopaminergic neurons, we double labeled midbrain neuronal cultures for TH and calbindin after FFN200 imaging (Fig. 1d) .
Calbindin is predominantly present in VTA and is absent in SN dopamine neurons 18 . In these cultures, 66% of TH-positive neurons expressed calbindin. FFN200-positive and FFN200-negative neurons exhibited comparable percentages of calbindin expression: 67% and 63%, respectively (40 cells, representative of two independent cell culture preparations). These results suggest that FFN200 does not discriminate between SN-and VTA-derived dopaminergic neurons in culture.
The distribution of FFN200 in cell bodies and dendrites of cultured neurons was diffuse, suggesting that, in addition to labeling VMAT2-containing organelles, a substantial fraction of the probe is located in the cytosol (Fig. 1d) . In axonal regions of cultured neurons, FFN200 fluorescence was characterized by a clear punctate pattern, which is likely to be the correlate of striatal slice FFN200 puncta, superimposed on a lighter diffuse signal that filled the axonal cytosol (Fig. 1e) . Triple colocalization between FFN200, TH and the synaptic vesicle protein synaptophysin revealed that 86 ± 6% of all TH-labeled FFN200 puncta expressed synaptophysin (total of 193 puncta from five cell culture preparations; Fig. 1e ). The data indicate that most FFN200 puncta represent sites of synaptic vesicle accumulation in cultured dopaminergic neurons.
FFN200 accumulation in striatal axons depends on VMAT2
To understand the mechanism of FFN200 accumulation, we investigated the putative role of the plasma membrane and synaptic vesicle dopamine transporters. No difference was found in the number and intensity of FFN200 puncta in the dorsolateral striatum of mice lacking the Slc6a3 gene, which encodes the DAT protein, and wild-type littermates using identical FFN200 loading protocols (number of puncta per field of view: wild type, 441.7 ± 35.2; DAT knockout (KO), 412.9 ± 33.4; n = 3 mice per condition with 2 slices averaged per mouse, P = 0.59, two-tailed unpaired t test; Fig. 2a,b) . DAT inhibition with nomifensine had no significant effect on striatal FFN200 accumulation (number of puncta: wild type, 418.8 ± 20.5; nomifensine, 434.8 ± 20.5; n = 4 mice per condition with two slices averaged per mouse, P = 0.60, two-tailed unpaired t test; Fig. 2a,b) . Moreover, FFN200 loading into cultured midbrain dopamine neurons was not impaired by either DAT KO (data not shown) or iso-osmotic replacement of Na + with choline (FFN200-labeled dopamine neurons: NaCl, 59.0 ± 12.0%; choline Cl, 60.0 ± 10.0%; n = 3 independent cell cultures, P = 0.95, two-tailed unpaired t test). Thus, FFN200, in contrast with FFN102 (ref. 13) , does not rely on DAT or other Na + -dependent transporters for loading into dopaminergic neurons. FFN200 puncta intensity was reduced by approximately 30% in the dorsolateral striatum of VMAT2 hypomorph striatal slices, which npg a r t I C l e S express ~5% of wild-type VMAT2 protein levels 19, 20 (Fig. 2c,d) .
A similar reduction in puncta intensity was observed following treatment with the VMAT2 inhibitor dihydrotetrabenazine (dTBZ) under conditions that led to maximal VMAT2 inhibition, as assessed by measuring evoked dopamine release with CV ( Fig. 2c,d and Supplementary Fig. 2 ). The entire distribution of FFN200 puncta intensities was shifted to lower values in both VMAT2 hypomorph and dTBZ-treated slices (Fig. 2e,f) , indicating that the majority of FFN200 puncta had lower intensity when VMAT2 activity was decreased. The number of FFN200 puncta was also reduced by dTBZ (control, 351.5 ± 9.8 puncta; dTBZ, 249.0 ± 2.9; n = 4 mice with 2 slices averaged per mouse, P < 0.0001, two-tailed unpaired t test) and in the VMAT2 hypomorphs (wild type, 378.7 ± 4.8 puncta; VMAT2 hypomorph, 265.5 ± 2.3; n = 5 mice with 2 slices averaged per mouse, P < 0.0001, two-tailed unpaired t test), which suggests that some puncta fell below the detection threshold as a result of decreased intensity. These data suggest that FFN200 loading in striatal slices is in part dependent on VMAT2, the majority of puncta have FFN200 in VMAT2-containing vesicles and ~30% of the total FFN200 in each punctum is located in VMAT2 vesicles.
FFN200 activity-induced release is strictly VMAT2 dependent Time lapse imaging of FFN200 puncta in striatal slices revealed that FFN200 was released into the extracellular space following perfusion with 40 mM KCl-containing buffer (Fig. 3a) , as measured by the increase in background intensity, that is, the average fluorescence intensity in non-punctal regions (given that high K + depolarization caused considerable tissue distortion, we did not analyze FFN200 destaining from individual puncta; Fig. 3b ). KCl depolarization also induced FFN200 release in midbrain dopamine neurons in culture (Fig. 3c,d) , confirming that the probe can be used to monitor dopamine exocytosis in cultured neurons. Notably, although most FFN200 puncta in cultured neurons colocalized with synaptophysin (86%; Fig. 1e ), a subset did not destain in response to KCl (Fig. 3c) . Moreover, substantial axonal FFN200 fluorescence remained, which is consistent with cytoplasmic localization of a fraction of FFN200 (Fig. 1d) . High K + depolarization did not significantly destain FFN200 in VMAT2 hypomorph striatal slices, as indicated by the lack of change in background fluorescence intensity (P < 0.0001, two-way ANOVA; Fig. 3a,b) . These results indicate that the majority of activity-induced FFN200 release in the striatum originates from VMAT2-expressing vesicles and that the remaining fluorescence of FFN200 puncta in VMAT2 hypomorphs is located in the cytoplasm or organelles that do not undergo stimulus-dependent exocytosis.
FFN200 provides monitoring of individual bouton exocytosis
Local electrical stimulation of striatal axons at 15 Hz, a frequency associated with dopamine neuron burst firing 21 , induced destaining of a subset of FFN200 puncta (Fig. 4a) . Representative time-lapse images and destaining curves for individual puncta showed a range of destaining kinetics (Fig. 4a,b) . Some puncta did not respond to stimulation and were indistinguishable from those in nonstimulated slices (Fig. 4a,b) . FFN200 release into the extracellular Figure 2 Effect of DAT and VMAT2 inhibition or genetic ablation on FFN200 loading in the dorsal striatum. (a,c) Representative images of FFN200-loaded striatal slices from wild-type and DAT KO (a) or VMAT2 hypomorph mice (VMAT2 hypo; c) (top panels) and of untreated control slices and slices treated with 5 µM nomifensine for 10 min before and during FFN200 incubation (a) or dTBZ-treated slices (5 µM dTBZ for 1 h before and during FFN200 loading; c) (bottom panels). (b,d) FFN200 puncta intensity in slices of versus DAT KO mice (n = 3) and in control versus nomifensine-treated slices (n = 4) (b), and in slices from wild-type versus VMAT2 hypomorph mice (n = 5) and in control versus dTBZ-treated slices (n = 4) (d). Puncta intensities were background-subtracted and normalized to the corresponding mean wild-type or control value and are plotted as a scatter plot including mean ± s.e.m.
(n = 3-5 mice, as indicated above, with two slices averaged per mouse) with significant differences indicated (two-tailed unpaired t test, *P < 0.05, **P < 0.01; wild-type versus DAT KO, P = 0.54; control versus nomifensine, P = 0.13; wild-type versus VMAT2 hypomorph, P = 0.0027; control versus dTBZ, P = 0.031). (e,f) Histograms of puncta intensities, in arbitrary units (a.u.), for all FFN200 puncta of wild-type versus VMAT2 hypomorph (e) and control versus dTBZ-treated slices (f). npg a r t I C l e S milieu was confirmed by measuring the increase in background intensity following stimulation (Fig. 4c) . This activity-induced release of FFN200 was Ca 2+ dependent, as the background intensity failed to increase in slices stimulated in the presence of the Ca 2+ channel blocker CdCl 2 (200 µM; Fig. 4c ) or in 0 mM Ca 2+ buffer ( Supplementary  Fig. 3a) . Consistently, changes in the intensity of FFN200 puncta in slices stimulated in the presence of Cd 2+ were indistinguishable from those of unstimulated slices (Fig. 4a,b) . Stimulation-evoked FFN200 destaining was blocked by 1 µM tetrodotoxin (TTX; Supplementary  Fig. 3a) . The results indicate a requirement for action potential conduction through axonal processes to evoke FFN200 release, similar to results from CV recordings of evoked dopamine release 3 .
To reliably analyze the FFN200 puncta that destain following stimulation, we developed a Matlab program to discriminate destaining from non-destaining puncta in a consistent and unbiased manner (Online Methods). We obtained a percentage of 'destaining' puncta of 4.0 ± 0.9%, 2.9 ± 0.6%, 4.7 ± 1.3% and 3.3 ± 1.1% for unstimulated slices and slices stimulated in the presence of Cd 2+ or TTX or in 0 mM Ca 2+ , respectively ( Fig. 4d and Supplementary Fig. 3b ), which represent the rate of false positives obtained with this method. The percentage of destaining puncta for 15-Hz stimulated slices was significantly higher at 17.2 ± 2.0% (P < 0.001, one-way ANOVA with Bonferroni's multiple comparison test; Fig. 4d) .
We examined the change in FFN200 puncta intensity over time, corrected for the baseline rundown, for destaining and non-destaining puncta (Fig. 4e) . There was an average of 28% evoked decrease in fluorescence per destaining punctum, consistent with the VMAT2 hypomorph and dTBZ data suggesting that ~30% of each punctum's fluorescence is present in VMAT2-containing compartments (Fig. 2b,d ). As evident from the first derivative of the destaining curve (Fig. 4f) , the loss in FFN200 intensity was greatest at the onset of stimulation and decreased thereafter. Individual destaining curves were fit by monoexponential decay functions and the distribution of destaining halftimes (t 1/2s ) was plotted (Fig. 4g) . The average of the median t 1/2 values obtained for each slice was 25.7 ± 2.5 s. Comparing FFN200 and FFN102 destaining at 15 Hz revealed slower destaining kinetics for FFN102 ( Supplementary Fig. 4c,d ). This may be a result of the pH dependence of FFN102 fluorescence, which, for example, complicates adequate background subtraction (we found a greater increase in FFN102 background fluorescence without a significant increase in the fraction of destaining puncta as a result of the increased FFN102 intensity at neutral pH at λ exc = 770 nm; P = 0.1269, two-tailed unpaired t test; Supplementary Fig. 4a ,b) 13 . The pH-independent fluorescence of FFN200 makes this probe a better indicator of neurotransmitter release kinetics.
We monitored FFN200 destaining at a range of stimulation frequencies and found that, although the percentage of destaining puncta did not change significantly (P = 0.1039 by one-way ANOVA; Fig. 5a ), destaining kinetics became faster with increased frequency, as expected (Fig. 5b,c) . Plotting the decrease of puncta intensity as a function of stimulation pulse number revealed that the amount of FFN200 released per pulse decreased as stimulation frequency increased ( Fig. 5d) , consistent with electrochemically recorded dopamine release in striatal brain slices 22, 23 . The t 1/2 of FFN200 release was reached at 318, 135, 41 and 5 stimulation pulses at 15, 4, 1 and 0.1 Hz, respectively. Moreover, ~17% of FFN200-labeled vesicles in the releasable pool underwent exocytosis in response to a single stimulus pulse (compare first stimulus at 0.1 Hz (4.7% decrease) to maximal release (28.5%); Fig. 5d ,e), consistent with the high levels of dopamine release elicited by individual pulses 22, 23 . Thus, FFN200 release triggered by a single stimulus can be measured with this approach.
FFN200 and FM1-43 reveal silent dopamine vesicle clusters
The percentage of FFN200 puncta that destained in response to 15 Hz stimulation was 17.2 ± 2.0% (Fig. 4d) . The density of striatal FFN200 puncta was found to be 0.126 ± 0.009 puncta µm −3 (determined in maximal projections of stacks of five z sections, acquired 0.5 µm apart; n = 5 slices from different mice), similar to the density of striatal dopamine synapses previously reported by serial section electron microscopy (~0.1 synapses µm −3 ; dopamine synapses were defined as a cluster of vesicles in close proximity to symmetric membrane densities in 5-OHDA-labeled axons) 24, 25 . npg a r t I C l e S The low fraction of destaining puncta is therefore unlikely to represent axonal regions that lack synaptic vesicles, as the density of FFN200 puncta would otherwise be considerably higher. Furthermore, the shift of the entire distribution of FFN200 puncta intensities to lower values in VMAT2 knockdown and inhibition experiments (Fig. 2e,f) indicates that the majority of FFN200 puncta contain the probe in VMAT2-expressing vesicles. Putative leakage of FFN200 from synaptic vesicles or depletion of vesicular FFN200 by spontaneous vesicle fusion could in principle occur during the 45-min wash time chosen for optimal signal selectivity. Decreasing the washout to 25 min, however, did not substantially increase the fraction of destaining puncta nor the amount of destaining ( Supplementary Fig. 5a,b) as would be expected if there were extensive leakage or spontaneous fusion. Moreover, non-destaining and destaining puncta exhibited similar mean fluorescence intensity immediately before stimulation (0.090 ± 0.005 a.u. versus 0.099 ± 0.005 a.u., respectively, for n = 15 slices from different mice, P = 0.1840 by unpaired two-tailed t test). Thus, although depletion of vesicular FFN200 may occur in some puncta, it is unlikely to be a major cause of the high fraction of unresponsive vesicle clusters.
As an alternative approach to estimate dopamine bouton activity, we used the endocytic dye FM1-43, which loads into recycling Non-destaining Destaining Baseline-corrected puncta intensity (% npg a r t I C l e S synaptic vesicles as they undergo endocytosis 6 . In neuronal cultures, lack of FM1-43 loading has been used to identify 'presynaptically silent' synapses that were otherwise labeled with general synaptic markers [26] [27] [28] [29] [30] . FM1-43 was loaded into striatal presynaptic boutons by local stimulation at 15 Hz, and was followed by FFN102 loading to identify dopamine structures (FFN102 was used as it requires shorter washes than FFN200, rendering the long labeling protocol feasible). Given that FM1-43 shows substantial non-specific binding, we used subsequent KCl depolarization to identify the specific activity-dependent signal in recycling vesicles (data not shown). We found that 10.4 ± 1.7% of activity-dependent FM1-43 puncta colocalized with FFN102 (n = 5 slices from different mice; Fig. 6 ). Notably, only 2.2 ± 0.5% of all FFN102 puncta loaded FM1-43 in an activity-dependent manner (Fig. 6) . This corresponds to a density of 0.0026 ± 0.0006 puncta µm −3 , about 2.5% of the reported density of striatal dopaminergic synapses (see above). The difference in the fraction of responsive dopaminergic vesicle clusters assessed with FFN200 destaining and FM1-43 loading may be a result of FM1-43 nonspecific binding and low signal-to-noise ratio, or to an effect of the pre-stimulus required to load this probe on synaptic function. Nonetheless, both optical approaches suggest a large number of functionally silent dopamine vesicle clusters in response to electrical stimulation of the dorsolateral striatum.
FFN200 non-destaining puncta exhibit typical Ca 2+ signals To determine whether the high fraction of FFN200 non-destaining puncta was a consequence of inefficient stimulation or impaired Ca 2+ influx, we investigated Ca 2+ signaling at striatal dopamine axons. The genetically encoded Ca 2+ indicator GCaMP3 was recently used in striatal dopamine axons to study the role of different Ca 2+ channels in evoked Ca 2+ transients, but individual bouton response was not assessed 31 . We generated transgenic mice expressing GCaMP3 in dopamine neurons by crossing the Ai38 floxed GCaMP3 reporter 32 and DAT IREScre (ref. 33) mouse lines. We confirmed the specificity of GCaMP3 localization in midbrain VTA and SN dopamine neurons of resulting DAT-GCaMP3 mice by immunohistochemistry, using antibodies to GFP and TH to identify GCaMP3 and dopamine neurons, respectively (98.1 ± 0.1% of GCaMP3 cell bodies were labeled for TH, 100% of TH cell bodies were colabeled with GCaMP3; n = 2 mice, 2 fields of view per mouse, each with 20-39 cells; Fig. 7a,b) . GCaMP3 was selectively expressed in dopamine axons, as the signal was mostly confined to the striatum and very low in the cortex and corpus callosum of striatal slices, matching the pattern of TH label (Fig. 7c) . We found a high degree of colocalization between GCaMP3-and TH-positive axonal profiles (73.6 ± 3.4% of GCaMP3 structures expressed TH, 79.7 ± 7.4% of TH axonal profiles colabeled for GCaMP3; n = 2 mice, 2 fields of view per mouse, each with 198-350 axonal structures; Fig. 7d) .
Imaging of GCaMP3 signals and FFN200 destaining from the same dopamine axonal structures was performed in striatal slices 
npg a r t I C l e S
by sequential line scanning of the two fluorophores. The fraction of FFN200-releasing puncta and t 1/2 of destaining in these experiments were 15.5 ± 1.1% and 16.8 ± 1.9 s (n = 4 slices from different mice), indicating that dopamine exocytosis was not affected in DATGCaMP3 animals. The vast majority of destaining puncta (85.2 ± 6.2%; Fig. 7e ) showed substantial increases in GCaMP3 fluorescence intensity in response to 15-Hz stimulation (Fig. 7f) . Notably, 65.0 ± 4.3% of non-destaining puncta also exhibited substantial increases in GCaMP3 signal following 15-Hz stimulation (Fig. 7e,f) . Non-destaining puncta lacking a GCaMP3 response to 15 Hz (Fig. 7e) were either not efficiently stimulated by our procedure or exhibited Ca 2+ signals below detection, as subsequent perfusion with 40 mM KCl induced GCaMP3 responses in 94.6 ± 2.6% (n = 4 slices from different mice) of these puncta. The amplitudes of the 15-Hz evoked GCaMP3 signals in responsive puncta were not significantly different between FFN200 destaining and non-destaining cohorts (P = 0.91, two-way ANOVA; Fig. 7g) . The amplitude of the GCaMP3 response to high K + , although higher on average than that evoked by 15-Hz stimulation, was also similar between destaining and non-destaining puncta (Fig. 7g) . Our results indicate that more than half of FFN200 non-destaining puncta exhibited Ca 2+ signals that were indistinguishable from those detected in destaining puncta, suggesting that their lack of transmitter release is a result of a factor downstream from Ca 2+ influx. We note, however, that Ca 2+ microdomains in the puncta are not resolved by these techniques and that differences in small regions, including the vicinity of active zones, are expected to regulate synaptic vesicle fusion.
Puncta that displayed a GCaMP3 signal, but no FFN200 release, in response to 15-Hz stimulation showed a substantial decrease in FFN200 fluorescence when subsequently stimulated with high K + (Fig. 7h) . In contrast, puncta that released FFN200 in response to 15-Hz stimuli displayed a significantly smaller response to KCl depolarization (KCl response slopes between time points 41 and 48: non-destaining puncta, −0.17 ± 0.04; destaining puncta, −0.07 ± 0.02; P = 0.049, two-tailed paired t test; Fig. 7h ). Thus, under certain conditions, silent vesicle clusters can be recruited to release.
DISCUSSION
We developed FFN200 as the first fluorescent probe to label monoamine neurons in both primary neuronal cultures and brain slice, and used it to identify unexpected heterogeneity among striatal dopaminergic vesicle clusters. The activity-dependent destaining of this probe in the striatum was fully dependent on VMAT2, confirming FFN200 as a selective optical tracer of monoamine exocytosis. We found that only ~17% of striatal FFN200-labeled vesicle clusters released the probe following electrical stimulation. Independent assessment of synaptic exocytotic activity with the well-characterized probe FM1-43 was also consistent with a low density of active dopamine synapses. The majority of FFN200 non-destaining puncta, however, exhibited stimulation-dependent Ca 2+ signals that were indistinguishable from those elicited at destaining puncta. These findings indicate that the majority of axonal sites containing synaptic vesicles capable of accumulating VMAT2 substrates are silent in response to activitydependent Ca 2+ influx in striatal slices.
FFN200 provides an effective tool for imaging exocytosis from striatal dopamine axons, as it is a monoamine-selective probe that does not require subsequent identification of monoamine boutons; its loading involves a simple incubation step and does not require transfection or any pre-stimulation steps that may cause synaptic plasticity, in contrast with synaptopHluorins and FM1-43; it is the first developed FFN that labels dopamine vesicle clusters both in neuronal cultures and in brain slices; and its pH-independent fluorescence enables a more accurate monitoring of destaining kinetics than the pH-dependent FFN102.
Although FFN102 loading is strictly DAT dependent 13 , FFN200 does not rely on DAT to enter the cell, and the means by which it crosses the plasma membrane are currently unknown. FFN200 specificity toward dopamine neuron cell bodies in culture is high, suggesting that the diffuse FFN200 signal throughout the cell relies on either an active Na + -independent cell-specific mechanism of loading or the presence of a cytosolic factor that retains FFN200 specifically in dopaminergic cells. FFN200 accumulation in striatal axonal sites was partly VMAT2 dependent: puncta intensity was reduced by ~30% and the entire distribution of intensities of individual puncta was shifted to lower values when VMAT2 function or expression was inhibited (Fig. 2d-f) , suggesting that the majority of puncta accumulate FFN200 in VMAT2-containing compartments. Notably, no activity-induced release of FFN200 was observed in VMAT2 hypomorph striatum (Fig. 3a,b) . Together, these results suggest that ~30% of the total FFN200 signal is in VMAT2-expressing compartments and can be destained in response to stimulation, providing a straightforward means to measure exocytosis from striatal dopaminergic axonal boutons, the primary monoaminergic input to the striatum 16, 17 .
The kinetics of FFN200 destaining from striatal boutons at high stimulation frequency is comparable to the kinetics of FM dye release in midbrain dopamine neuronal cultures 9 and hippocampal slice CA3-CA1 synapses 34 (t 1/2s of ~25 s at 10 Hz). At lower stimulation frequencies, however, FFN200 release from striatal boutons was faster than FM1-43 release from glutamatergic synapses (t 1/2 of ~130 s at 1 Hz) 34 . This parallels the high level of dopamine release recorded electrochemically in the slice preparation in response to a single stimulus (or the first of a train of pulses) 22, 23 , which is mostly attributed to nicotinic receptor activation 35, 36 . Dopamine release decreases sharply in response to subsequent stimuli in a frequency-dependent manner (higher frequencies result in higher inhibition) 22, 23, 35, 36 . Our results are therefore consistent with the kinetics of dopamine release measured by CV and they further suggest that the high level of single pulse-evoked dopamine release is a result of exocytosis of a considerable fraction of releasable vesicles (~17%; Fig. 5d,e) . In comparison, glutamate synapses release less than 1% of their vesicle pool per action potential measured, however, by a technique with a different readout mechanism (endocytic dyes) 34 . FFN200 imaging at striatal dopamine axons revealed a surprisingly small fraction of destaining vesicle clusters in response to stimulation. It seems unlikely that the large cohort of unresponsive puncta represent axonal areas lacking labeled synaptic vesicles given that the density of FFN200 puncta was similar to the reported density of dopamine synapses in rat striatum 24, 25 , the majority of FFN200 puncta showed decreased fluorescence intensity following VMAT2 knockdown or inhibition, and the fraction of FFN102-tagged striatal dopamine axonal sites that loaded the endocytic probe FM1-43 was very low (Fig. 5) . Moreover, the majority of non-destaining puncta displayed electrically evoked Ca 2+ signals that were indistinguishable from those in destaining puncta, as monitored by GCaMP3 imaging (Fig. 6f,g ). FFN200 non-releasing axonal sites therefore contain the probe in VMAT2-expressing vesicles and exhibit Ca 2+ influx in response to stimulus trains, but fail to release transmitter.
Although release in response to a single stimulus can be measured with this approach, we cannot exclude the possibility that non-destaining puncta release a low amount of FFN200 that is below detection limits. Techniques resolving single-vesicle exocytosis in the brain slice will be required to address this issue. Our results also do not address npg a r t I C l e S whether a similarly high fraction of non-releasing vesicle clusters occurs in vivo or how the slice preparation may affect factors that regulate neurotransmission. We note, however, that FFN200 release was observed in response to KCl stimulation from puncta that did not destain in response to 15 Hz, suggesting that some silent vesicle clusters are capable of release under certain conditions.
Presynaptically silent synapses were initially proposed in studies of the neuromuscular junction and motoneuron synapses [37] [38] [39] and have been recently described in hippocampal glutamatergic [26] [27] [28] and GABAergic 29, 40 neurons, and cerebellar granule neurons 30, 41 . Our study represents, to the best of our knowledge, a first report on silent neuromodulatory synapses. Moreover, the ability of FFN200 to label both active and silent vesicle clusters enabled, to the best of our knowledge, the first direct quantification of presynaptically silent synapses in brain tissue. The absence of exocytosis in silent dopaminergic vesicle clusters could be a result of multiple mechanisms, including a local inhibitory factor impairing vesicle fusion downstream from Ca 2+ entry or the lack of a component essential for exocytosis. Previous reports have suggested that modulation of vesicle priming, for example, may underlie presynaptic silencing 42, 43 . Another possibility would be lack of an active zone in close proximity to most FFN-labeled vesicle clusters; note, however, that the density of striatal dopamine synapses, as defined by a cluster of vesicles juxtaposed to symmetric membrane densities, closely matches the density of FFN200 puncta. It is unlikely that the majority of non-destaining vesicle clusters represent synaptic vesicles traveling along the axon en route to an actual synapse, as the majority of puncta (>95%) remained stationary for imaging periods up to ~13 min (data not shown).
Given that dopaminergic axons cover very extensive areas in the striatum 44 , restricting dopamine release to a minority of axonal sites would confer spatial selectivity to the modulation of striatal synapses by dopamine. Small 'hot spots' of high dopamine release have been reported in response to sucrose and ethanol-directed behaviors 45, 46 . Silent axonal sites could underlie the size and location of such hot spots. Silent dopamine vesicle clusters may also be involved in the formation of new release sites, as suggested for presynaptically silent glutamatergic synapses in the hippocampus [47] [48] [49] . Indeed, a theory of motor learning in the cerebellum assumes a preponderance of presynaptically silent granule cell synapses 50 and may be a useful model for basal ganglia learning. Finally, the state of silent vesicle clusters may be important in disorders such as schizophrenia, which show striatal hyperdopaminergia and cortical hypodopaminergia, and processes of 'unsilencing' may have clinical applications for diseases such as Parkinson's disease.
METhODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METhODS
materials. FFN200 and FFN102 were synthetized in our laboratories. (+)−(2R,3R,11bR)-alpha-dihydrotetrabenazine (dTBZ) was a gift from the National Institute of Mental Health (NIMH) Chemical Synthesis and Drug supply program (http://nimh-repository.rti.org/) while racemic TBZ, used for K m determination, was from Sigma-Aldrich. The anti-TH mouse monoclonal (MAB5280) and rabbit polyclonal (657012) antibodies as well as the anti-GFP rabbit polyclonal antibody (AB3080) were from Millipore/Calbiochem, the mouse monoclonal anti-synaptophysin antibody (IR776; clone SY38) was from DAKO and the mouse monoclonal anti-calbindin D-28K antibody (C9848; clone CB-955) was from Sigma-Aldrich. Secondary anti-mouse and anti-rabbit antibodies conjugated to either Alexa 488 or Alexa 594, as well as FM1-43, were from Molecular Probes (Life Technologies) and the ADVASEP-7 was from Cydex Pharmaceuticals. HEPES, DMEM and FBS were from Invitrogen (Life Technologies). AP-5, NBQX and TTX were from Tocris Bioscience. All other reagents were from Sigma-Aldrich. A traditional shake flask method was employed in the test. The probe concentration in octanol and aqueous layers was determined using fluorimetry and subsequently fitting the respective values onto calibration curves. All measurements were performed at three different concentrations in duplicate. Probe stock solution was added to a mixture of octanol and pH 7.4 potassium phosphate buffer and thoroughly mixed by inverting the tube at least 100 times and subsequently spinning at 3,000 rpm for 5 min to facilitate phase separation. The probe concentrations in each layer were determined by interpolation from standard curves of fluorescence emission of the probe against concentration. 51 . Cells were plated at 0.03-0.04 × 10 6 cells per well in poly-d-lysine-coated (0.1 mg ml −1 ) 96-well plates. No signs of mycoplasma contamination were observed by nuclear staining. After reaching confluence (~3 d), cells were incubated with TBZ (2 µM, 100 µl per well) or DMSO vehicle (0.02%) for 1 h in experimental medium (DMEM without phenol red containing 25 mM HEPES and 1% FBS). Cells were then incubated with FFN200 at different concentrations (50, 25, 12.5, 6, 3, and 1 µM), together with 2 µM TBZ or DMSO in experimental medium, for 12 min at 22-24 °C. FFN200 uptake was terminated by washing with PBS and fluorescence was measured in each well with a BioTek H1MF plate reader (BioTek) in bottom read mode with excitation and emission wavelengths of 352 nm and 451 nm, respectively. The specific uptake at each concentration of FFN200 was determined by subtracting the fluorescence intensity of TBZ-treated cells from that of uninhibited (DMSO-treated) cells, and was linear for concentrations of FFN200 of 50 µM or less for times up to 12 min. The initial rates of specific uptake for each concentration were fit to the Michaelis-Menten equation using GraphPad Prism 5 (GraphPad Software) to derive the K m value for FFN200 uptake by VMAT2. Each experiment consisted of duplicate plates, and K m was calculated from the mean of three independent experiments. mice. All animal protocols followed US National Institutes of Health guidelines and were approved by Columbia University's Institutional Animal Care and Use Committee. Mice were housed in groups of five or less per cage, in a 12-h day/12-h night cycle with ad libitum access to food and water. TH-GFP mice 15 were kindly provided by K. Kobayashi (Fukushima Medical University) and the DAT KO mice 52 were a kind gift of M. Caron (Duke University). A. Salahpour (University of Toronto) kindly provided the VMAT2 hypomorph mice 19, 20 . Wild-type C57BL/6 mice and the DAT IREScre (ref. 33 , strain name: B6.SJLSlc6a3 tm1.1(cre)Bkmn /J) and Ai38 floxed GCaMP3 reporter 32 (strain name: B6;129S-Gt(ROSA)26Sor tm38(CAG-GCaMP3)Hze /J) mouse lines were obtained from The Jackson Laboratory. To obtain transgenic mice expressing GCaMP3 in dopamine neurons, we crossed the Ai38 floxed GCaMP3 reporter and DAT IREScre mouse lines. The Ai38 mice express GCaMP3 from the ROSA26 locus, driven by a CAG promoter, in a Cre-dependent manner due to the presence of a lox-stop-lox cassette. Crossing with DAT IREScre mice, which express the Cre recombinase under the transcriptional control of the endogenous DAT promoter, leads to selective GCaMP3 expression in DAT-expressing tissues. DAT IREScre/wt heterozygous mice were crossed with heterozygous Ai38 mice and the resulting heterozygous mice for both transgenes were identified by PCR according to protocols provided on the vendor's website and used in all GCaMP3 imaging experiments. We termed these animals "DAT-GCaMP3" mice.
Preparation of wild-type and transgenic mouse brain slices. Striatal slices were prepared as previously described 13 , with minor modifications. Briefly, 7-12 week-old mice were killed by cervical dislocation and decapitated. Wildtype male mice were used and in the case of the transgenic mice, both female and male DAT-GCaMP3 animals were used (due to limited number of animals available), while sex-matched transgene and control littermates were used in experiments with DAT knockouts and VMAT2 hypomorphs. Three of five sets of VMAT2 hypomorph and wild-type littermates were 16-22 weeks old. Since results did not differ between animals of different age, data from both groups were pooled together. Acute 250 µm thick coronal brain slices were cut on a Leica VT1200 vibratome (Leica Microsystems), kept at 22-25 °C cell culture preparation. Ventral midbrain neuronal cultures derived from postnatal day 0-3 mouse pups were prepared as previously described 53 . A detailed protocol is available on our laboratory's website (http://sulzerlab.org/ Sulzer_VM_culture_protocol_book_version6%201.pdf). Briefly, neurons were dissociated and plated at a density of approximately 100,000 neurons cm −2 on a layer of rat cortical glial cells grown on either round glass coverslips or glass bottom culture dishes. They were maintained in culture medium supplemented with 10 ng ml −1 glial cell line-derived neurotrophic factor in a 5% CO 2 incubator at 37 °C for 2-3 weeks.
FFn loading and imaging. Brain slices. Striatal slices were incubated in ACSF with 10 µM FFN for 30 min at 22-24 °C and washed for 20 min in the case of FFN102 or 45-50 min for FFN200 (a washout of at least 45 min is needed to ensure optimal selectivity toward striatal dopamine boutons; not shown), unless otherwise indicated. For the DAT and VMAT2 inhibition experiments, slices were pre-incubated with either 5 µM nomifensine for 15 min or 5 µM dTBZ for 1 h before FFN200 incubation in the presence of 5 µM of the corresponding inhibitor. npg Slices were then washed for 45 min in the absence of any drugs before the onset of imaging. For the DAT KO and VMAT2 hypomorph experiments, wild-type and transgenic slices were imaged on the same day, at approximately the same time after sectioning, under the same conditions. For TH-GFP colocalization and pharmacology experiments, slices were imaged by two-photon microscopy on a Leica SP5 confocal/multi-photon microscope (Leica Microsystems) equipped with a Spectra-Physics BB titanium-sapphire pulsed laser (Newport) and either a 40× 0.8 NA (Olympus; TH-GFP colocalization experiments) or a 63× 0.9 NA (Leica Microsystems; dTBZ and nomifensine inhibition experiments) water immersion objective. For all other experiments, slices were imaged on Prairie Ultima Multiphoton Microscopy Systems (Bruker/Prairie Technologies) equipped either with a Spectra-Physics MaiTai HP DeepSee titanium-sapphire pulsed laser (Newport) or Coherent Chameleon Ultra II and Vision II titanium-sapphire pulsed lasers (Coherent) and either a 60× 0.9 NA (Olympus) or a 63× 1.0 NA (Carl Zeiss Microscopy) water immersion objective. Slices were placed in a QE-1 imaging chamber (Warner Instruments), held in place with a custom-made platinum wire and nylon holder 54 , and superfused with oxygenated ACSF (2-3 ml min −1 ) using an Instech peristaltic pump (Instech Laboratories). All images were acquired at a depth of at least 30 µm. TH-GFP colocalization experiments were performed on the Leica microscope as described previously 13 . Briefly, FFN200 and GFP were detected by sequential imaging of the same sample field (single z-plane 8-bit images; 38 × 38 µm field of view; 512 × 512 pixel resolution) using the following parameters: GFP was excited at 910-920 nm and detected in the wavelength range of 510-600 nm; FFN200 was excited at 760 nm and detected at 440-490 nm. Lack of signal bleed-through between the FFN200 and GFP channels was confirmed by acquiring FFN200-GFP image sequences in FFN200-incubated wild type slices and in TH-GFP slices devoid of FFN200. To avoid underestimating GFP-FFN200 colocalization due to shifts in the z-plane, we acquired FFN200-GFP-FFN200 sequences and discarded any sequences showing less than 85% colocalization between the first and second FFN images. All other FFN200 imaging experiments were performed using excitation wavelengths of 740-770 nm and an emission range of 440-500 nm. For nomifensine and dTBZ experiments, single z-plane 8-bit images were acquired on the Leica two-photon microscope with a size of 41 × 41 µm at 512 × 512 pixel resolution. For the DAT KO and VMAT2 hypomorph experiments, single z-plane 12-bit images were acquired on a Prairie two-photon microscope with a 38 × 38 µm field of view at 512 × 512 pixel resolution. Imaging parameters for the KCl and electrical destaining experiments, including the ones using DAT-GCaMP3 mice, will be detailed in a following section. All live brain slice imaging experiments were conducted at 22-24 °C.
Cell culture. Ventral midbrain neuronal cultures prepared as above on glass coverslips were incubated for 30 min at 37 °C with 10 or 20 µM FFN200 in the presence of 50 µM AP-5 and 10 µM NBQX, in culture medium. Cultures were then transferred into closed imaging chambers (RC-21BRFS, 260 µl volume, Warner Instruments) and perfused (0.5 ml min −1 ) with Tyrode's solution (in mM: 119 NaCl, 2.5 KCl, 25 HEPES sodium salt, 2 MgCl 2 , 2 CaCl 2 , 30 glucose, 50 µM AP-5, 10 µM NBQX, pH 7.5; osmolarity, 320 mOsm) at 24-26 °C. Following at least 10 min of Tyrode's superfusion to wash out FFN200, images were acquired using MetaMorph software (Molecular Devices) on an Olympus IX8-ZDC inverted fluorescence microscope with focus drift compensation (Olympus) equipped with a ProScan digitized stage (Prior Scientific) and a Photometrics Cool Snap HQ camera (Roper Scientific). For high potassium destaining experiments, images were acquired every 5 s at 200 ms exposure time using a 60× 1.35 NA oil objective (Olympus), a fluorescence filter set for DAPI (#3100v2; Chroma Technology) and a 1.3 neutral density filter. Solutions were switched from regular Tyrode's to 90 mM KCl-containing Tyrode's solution (in mM: 31.5 NaCl, 90 KCl, other components same), for at least 1 min, with a perfusion valve control system (Warner Instruments). For immunostaining experiments, stage positions of FFN200-labeled cell bodies were recorded before fixation. For synaptophysin staining, fixative was added to the culture dish while FFN200 images were being acquired. This method allowed us to minimize underestimating the colocalization between FFN200 and synaptophysin caused by movement of FFN-labeled organelles. FFN200, calbindin and TH colocalization images were acquired on a Zeiss Axiovert 100 microscope equipped with a Zeiss AxioCam MRm camera using a 20 × 0.5 NA objective (Carl Zeiss Microscopy).
Immunocytochemisty. Cultures were fixed with 4% paraformaldehyde for 5 min at 22-24 °C, followed by 10 min in 100% methanol at −20 °C. Cultures were then stained overnight at 4 °C with anti-calbindin antibody at 1:400, anti-TH antibody at 1:500-1:1,000 or anti-synaptophysin antibody at 1:100, followed by incubation with secondary antibodies conjugated to Alexa Fluor 350, 488 or 594, at 1:200, for 1 h at 22-24 °C.
Immunohistochemistry and imaging of dAt-gcamP3 mouse brain cryosections. DAT-GCaMP3 mice were superfused with phosphate-buffered 4% paraformaldehyde and their brains were postfixed overnight and cryoprotected in 30% sucrose for 2 d. Coronal cryosections of the midbrain and striatum were cut at 30-40-µm thickness and blocked overnight in phosphate buffered saline with 0.03% Triton (PBS-T) and 10% normal donkey serum (NDS). Sections were immunostained with rabbit anti-GFP (1:500) and mouse anti-TH (1:1,000) antibodies overnight at 4 °C (in PBS-T with 2% NDS), following by a 1 h incubation at 22-24 °C in donkey anti-rabbit Alexa 488 and anti-mouse Alexa 594 antibodies (both 1:400). The two fluorophores were visualized on mounted sections by sequential imaging using the Leica SP5 confocal/multi-photon microscope (Leica Microsystems) using the Argon 488 and DPSS 561 lasers and emission wavelengths of 500-550 and 590-680 nm, respectively. No signal bleed-through was observed between channels when imaging single-stained slices, using these conditions. Low magnification images of the ventral midbrain and dorsolateral striatum were taken with a 10× 0.3 NA dry objective (stacks of z sections taken every 5 µm in a volume of 25-30 µm; 911 × 911 µm field of view; 1,024 × 1,024 pixel resolution). For higher magnification images, 20× 0.7 NA and 63× 1.4 NA oil objectives were used for SN neurons (similar parameters as above but with a 456 × 456 µm field of view) and dorsolateral striatum axonal profiles (stacks of z sections taken every 100 nm in a volume of ~2 µm; 49 × 49 µm field of view; 1024 × 1024 pixels), respectively, which were subsequently used for quantification. Colocalization between GCaMP3 and TH in SN cell bodies and dorsostriatal axonal structures was determined on single z-sections essentially as previously described 13 using Volocity's 'Measure Object Colocalization' task. A colocalization coefficient of 0.5 or higher was considered to be indicative of colocalization. Intensity threshold and size parameters were adjusted for the size and signal to noise ratio of the structures analyzed.
High k + -and electrical stimulation-induced FFn destaining in brain slices. FFN200 and FFN102 release in response to K + depolarization or local electrical stimulation was monitored by time-lapse imaging on a Prairie Ultima Multiphoton Microscope (see above) with some modifications from the methods described previously 13 . FFN-labeled slices were imaged using excitation wavelengths of 740-770 nm and an emission range of 440-500 nm. To compensate for shifts in the z plane, z-stacks comprised of five 12-bit images acquired every 0.5 µm were continuously acquired over time and z sections representing the same field of view were selected for all time points for quantification. Image acquisition was performed averaging four frames of 22.5 × 22.5 µm and 256 × 256 pixels using a dwell time/pixel of 4.4 µs. This resulted in a time frame of 10-11s/z-stack. High K + -induced destaining of FFN200 was performed by switching the perfusion solution to ACSF containing 40 mM KCl (prepared by isotonic replacement of NaCl), for at least 90 s, using a Rheodyne 7010 switching valve (Rheodyne/IDEX). For electrical stimulation experiments, the AMPA and NMDA receptor inhibitors NBQX (10 µM) and AP-5 (50 µM), respectively, were present in the perfused ACSF for 10 min before the onset of imaging and throughout the remainder of the experiment to prevent glutamatergic excitotoxicity. Slices were imaged for 35 time points and local electrical stimulation was applied from the beginning of time point 21 to the end of the recording. Stimulation pulses (each pulse 600 µs × 100 µA; number of pulses: 16, 160, 640 and 2,400, at 0.1, 1, 4 and 15 Hz, respectively) were applied locally to the dorsal striatum by an Iso-Flex stimulus isolator triggered by a Master-8 pulse generator (AMPI), using platinum bipolar electrodes (Plastics One). All images were acquired within 50-100 µm of one of the stimulating electrode poles. For Cd 2+ and TTX experiments, 200 µM CdCl 2 or 1 µM TTX were present for 20 min before imaging and throughout the experiment. For 0 mM Ca 2+ experiments, perfusion was switched to ACSF containing 2.4 mM MgCl 2 instead of CaCl 2 and 1 mM EGTA, 10 min before imaging onset. For the imaging of GCaMP3 and FFN200 destaining, slices were imaged essentially as above with the following exceptions. Images were continuously acquired in two channels with an interlaced sequential line scanning pattern using different imaging parameters for the two probes: FFN200 was excited at 770 nm and detected at an emission range of 435-485 nm and GCaMP3 was excited at 900 nm npg
